A passport and visa are required. Visas should be obtained in advance, although airport visas are available. Travelers who opt to obtain an airport visa should expect delays upon arrival. There is a fee for the visa, whether obtained in advance or at the airport. Evidence of yellow fever immunization may be requested. Travelers to Kenya and neighboring African countries should ensure that the validity of their passports is at least six months, and that their passport contains sufficient blank pages for visas and immigration stamps.
See the Foreign Entry Requirements brochure for more information on Kenya and other countries.
Embassy
in the US :
Travelers may obtain the latest information on visas as well as any additional details regarding entry requirements from the Embassy of Kenya, 2249 R St., NW, Washington, DC 20008 (202-387-6101) or the Kenyan Consulates General in Los Angeles and New York City
Internet:
www.kenyaembassy.com
Kenya
Travel
Health Information :
Vaccination or Disease
Recommendations or Requirements for Vaccine-Preventable Diseases
Recommended if you are not up-to-date with routine shots such as, measles/mumps/rubella (MMR) vaccine, diphtheria/pertussis/tetanus (DPT) vaccine, etc.
CDC yellow fever vaccination recommendation for travelers to Kenya: For all travelers >9 months of age. The cities of Nairobi and Mombasa have lower risk of transmission than rural areas. Kenya requires travelers arriving from countries where yellow fever is present to present proof of yellow fever vaccination. Vaccination should be given 10 days before travel and at 10 year intervals if there is on-going risk. Find an authorized U.S. yellow fever vaccination clinic .
Recommended for all unvaccinated people traveling to or working in countries with an intermediate or high level of hepatitis A virus infection ( see map ) where exposure might occur through food or water. Cases of travel-related hepatitis A can also occur in travelers to developing countries with "standard" tourist itineraries, accommodations, and food consumption behaviors.
Recommended for all unvaccinated persons traveling to or working in countries with intermediate to high levels of endemic HBV transmission ( see map ) and who might be exposed to blood or body fluids, have sexual contact with the local population, or be exposed through medical treatment, such as for an accident, and for all adults requesting protection from HBV infection.
Recommended for all unvaccinated people traveling to or working in East Africa, especially if visiting smaller cities, villages, or rural areas and staying with friends or relatives where exposure might occur through food or water.
Recommended for travelers spending a lot of time outdoors, especially in rural areas, involved in activities such as bicycling, camping, hiking, or work. Also, children are considered at higher risk because they tend to play with animals and may not report bites.
Recommended for adult travelers who have received a primary series with either inactivated poliovirus vaccine (IPV) or oral polio vaccine (OPV). They should receive another dose of IPV before departure.
Malaria
Drugs to Prevent Malaria (antimalarial drugs)
If you will be visiting a malaria risk area in Kenya, you will need to take one of the following antimalarial drugs: atovaquone/proguanil , doxycycline , or mefloquine ( primaquine in special circumstances and only after G6PD testing).
Note: Chloroquine is NOT an effective antimalarial drug in Kenya and should not be taken to prevent malaria in this region.
Malaria risk area in Kenya: Risk in all areas (including game parks) at altitudes below 2,500 m (<8,202 ft). No risk in Nairobi.
